Literature DB >> 9300581

Weekly short infusions of gemcitabine are not associated with suppression of lymphatic activity in patients with solid tumors.

T Daikeler, K Maas, J T Hartmann, L Kanz, C Bokemeyer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9300581     DOI： 10.1097/00001813-199707000-00014

Source DB:  PubMed          Journal:  Anticancer Drugs        ISSN： 0959-4973            Impact factor:   2.248


× No keyword cloud information.
  2 in total

1.  Modified vaccinia Ankara expressing survivin combined with gemcitabine generates specific antitumor effects in a murine pancreatic carcinoma model.

Authors:  Hidenobu Ishizaki; Edwin R Manuel; Guang-Yun Song; Tumul Srivastava; Sabrina Sun; Don J Diamond; Joshua D I Ellenhorn
Journal:  Cancer Immunol Immunother       Date:  2010-10-20       Impact factor: 6.968

2.  Gemcitabine alters the proteasome composition and immunopeptidome of tumour cells.

Authors:  A M Gravett; N Trautwein; S Stevanović; A G Dalgleish; J Copier
Journal:  Oncoimmunology       Date:  2018-03-06       Impact factor: 8.110
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.